Mike O. Becker
Zurich, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Understanding patient-reported disease burden in systemic sclerosis: key clinical and demographic features revealed by the EULAR Systemic Sclerosis Impact of Disease (ScleroID) Questionnaire.
Journal: EULAR rheumatology open
Published: August 01, 2026
Radiomic analysis of high-resolution computed tomography predicts interstitial lung disease progression and mortality in systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: April 15, 2026
Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database.
Journal: Journal of autoimmunity
Published: February 05, 2026
First profiling of the national Swiss Clinical Quality Management giant cell arteritis and polymyalgia rheumatica registry.
Journal: Clinical and experimental rheumatology
Published: January 12, 2026
From sudden hearing loss to an inflammatory systemic disease
Journal: Innere Medizin (Heidelberg, Germany)
Published: November 19, 2025
A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC score.
Journal: Rheumatology (Oxford, England)
Published: April 14, 2025
The serum levels of specific autoantibodies in systemic sclerosis predict a more severe skin involvement.
Journal: Journal of scleroderma and related disorders
Published: March 26, 2025
Emphysema elevates the DETECT scores: impact on pulmonary hypertension screening and diagnosis in systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: February 04, 2025
The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133).
Journal: Annals of the rheumatic diseases
Published: February 03, 2025
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort.
Journal: Rheumatology (Oxford, England)
Published: October 16, 2024
Validation of a semi-quantitative method to assess interstitial lung disease severity and progression in systemic sclerosis by standard and low-dose HRCT scans.
Journal: RMD open
Published: September 24, 2024
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study.
Journal: The Lancet. Rheumatology
Published: August 01, 2024
Last Updated: 09/26/2026